US Patent Number
9,835,621
Publication Date
12-5-2017
Abstract
Disclosed is a method of detecting a concentration of a biomarker in a human subject having or being at risk of developing Alzheimer's disease or Mild Cognitive Impairment (MCI). Also disclosed is a process for detecting a concentration of a biomarker in a human subject having or being at risk of developing Alzheimer's disease or Mild Cognitive Impairment (MCI) comprising (a) detecting a first concentration of lipocalin-PDS/TTR complex in a blood sample or urine sample from the subject, (b) determining a second concentration of PDS/TTR complex in a blood sample or urine sample from an unaffected individual, and ( c) comparing the first and second concentrations, wherein a lower first concentration as compared to the second concentration is indicative of the subject having or being at risk of developing Alzheimer's disease.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
14/232,863
Filing Date
07/16/2012
Recommended Citation
Lovell, Mark A. and Lynn, Bert C., "Process for Detection of Alzheimer's Disease from a Serum Sample" (2017). Chemistry Faculty Patents. 36.
https://uknowledge.uky.edu/chemistry_patents/36
